Mark G. Foletta - Insider Trading & Ownership

Location
Amylin Pharmaceuticals Inc, 9360 Towne Centre Dr, San Diego, CA
Summary
The estimated net worth of Mark G. Foletta is at least $5.13M dollars as of August 18, 2025. Mark G. Foletta is the Director of DEXCOM INC and owns shares of DEXCOM INC (DXCM) stock worth about $4.63M. Mark G. Foletta is the Director of AMN HEALTHCARE SERVICES INC and owns shares of AMN HEALTHCARE SERVICES INC (AMN) stock worth about $496K.
Signature
/s/ Jereme M. Sylvain, as Attorney-in-Fact for Mark G. Foletta
All Insider Reports
All Insider Reports

Ownership of Mark G. Foletta

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
DXCM DEXCOM INC Director $4.63M -$686K -12.9% Aug 15, 2025
AMN AMN HEALTHCARE SERVICES INC Director $496K May 2, 2025
ENTA ENANTA PHARMACEUTICALS INC Director Mar 13, 2025

Insider Transactions Reported by Mark G. Foletta:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.